Current Status of and Perspectives on Cervical Cancer Screening in Korea

Since the introduction of the Papanicolaou (Pap) smear system in 1943, cervicovaginal cytology has been used as a standard screening test for cervical cancer. The dissemination of this test contributed to reductions of the incidence and mortality of cervical cancer worldwide. In Korea, regular healt...

Full description

Bibliographic Details
Main Authors: Sung-Chul Lim, Chong Woo Yoo
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2019-07-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2019-04-11.pdf
_version_ 1819038751315197952
author Sung-Chul Lim
Chong Woo Yoo
author_facet Sung-Chul Lim
Chong Woo Yoo
author_sort Sung-Chul Lim
collection DOAJ
description Since the introduction of the Papanicolaou (Pap) smear system in 1943, cervicovaginal cytology has been used as a standard screening test for cervical cancer. The dissemination of this test contributed to reductions of the incidence and mortality of cervical cancer worldwide. In Korea, regular health check-ups for industrial workers and their family members were introduced in 1988 and were performed as part of the National Cancer Screening Program in 1999. As a result, the incidence of cervical cancer in Korea has been steadily decreasing. However, about 800 cases of cervical cancer-related deaths are reported each year due to false-negative test results. Hence, new screening methods have been proposed. Liquid-based cytology (LBC) was introduced in 1996 to overcome the limitations of conventional Pap smears. Since then, other LBC methods have been developed and utilized, including the human papilloma virus test—a method with higher sensitivity that requires fewer screenings. In this study, we review current issues and future perspectives related to cervical cancer screening in Korea.
first_indexed 2024-12-21T08:42:17Z
format Article
id doaj.art-c7cfb1222d6445e98df4a6510115392c
institution Directory Open Access Journal
issn 2383-7837
2383-7845
language English
last_indexed 2024-12-21T08:42:17Z
publishDate 2019-07-01
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
record_format Article
series Journal of Pathology and Translational Medicine
spelling doaj.art-c7cfb1222d6445e98df4a6510115392c2022-12-21T19:09:55ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452019-07-0153421021610.4132/jptm.2019.04.1116837Current Status of and Perspectives on Cervical Cancer Screening in KoreaSung-Chul LimChong Woo Yoo0 Center for Uterine Cancer and Department of Pathology, National Cancer Center, Goyang, KoreaSince the introduction of the Papanicolaou (Pap) smear system in 1943, cervicovaginal cytology has been used as a standard screening test for cervical cancer. The dissemination of this test contributed to reductions of the incidence and mortality of cervical cancer worldwide. In Korea, regular health check-ups for industrial workers and their family members were introduced in 1988 and were performed as part of the National Cancer Screening Program in 1999. As a result, the incidence of cervical cancer in Korea has been steadily decreasing. However, about 800 cases of cervical cancer-related deaths are reported each year due to false-negative test results. Hence, new screening methods have been proposed. Liquid-based cytology (LBC) was introduced in 1996 to overcome the limitations of conventional Pap smears. Since then, other LBC methods have been developed and utilized, including the human papilloma virus test—a method with higher sensitivity that requires fewer screenings. In this study, we review current issues and future perspectives related to cervical cancer screening in Korea.http://www.jpatholtm.org/upload/pdf/jptm-2019-04-11.pdfUterusCervix uteriNeoplasmsScreeningPapanicolaou testHuman papillomavirus DNA testsPerspectives
spellingShingle Sung-Chul Lim
Chong Woo Yoo
Current Status of and Perspectives on Cervical Cancer Screening in Korea
Journal of Pathology and Translational Medicine
Uterus
Cervix uteri
Neoplasms
Screening
Papanicolaou test
Human papillomavirus DNA tests
Perspectives
title Current Status of and Perspectives on Cervical Cancer Screening in Korea
title_full Current Status of and Perspectives on Cervical Cancer Screening in Korea
title_fullStr Current Status of and Perspectives on Cervical Cancer Screening in Korea
title_full_unstemmed Current Status of and Perspectives on Cervical Cancer Screening in Korea
title_short Current Status of and Perspectives on Cervical Cancer Screening in Korea
title_sort current status of and perspectives on cervical cancer screening in korea
topic Uterus
Cervix uteri
Neoplasms
Screening
Papanicolaou test
Human papillomavirus DNA tests
Perspectives
url http://www.jpatholtm.org/upload/pdf/jptm-2019-04-11.pdf
work_keys_str_mv AT sungchullim currentstatusofandperspectivesoncervicalcancerscreeninginkorea
AT chongwooyoo currentstatusofandperspectivesoncervicalcancerscreeninginkorea